DNA RNA and Cells
9 January 2014
Cardio3 BioSciences Receives IND Clearance from the FDA for its CHART-2 Phase III Heart Failure Clinical Trial8 January 2014
Target Enrollment Achieved in CAVATAK™ USA Phase 2 Melanoma Trial with Excellent Interim Results19 December 2013
Athersys Confirms Completion of Patient Enrollment of Pfizer’s Phase II Study of MultiStem(R) Cell Therapy for Ulcerative Colitis17 December 2013
Capricor Therapeutics Cleared to Begin Phase II Portion of ALLSTAR Clinical Trial with CAP-1002 in Patients Following Heart Attack16 December 2013
OncoSec Medical Announces Positive Interim Data from Phase 2 Study of OMS-I100 in Metastatic Melanom14 December 2013
Cellular Biomedicine Group Announces Completion of Patient Treatment for Phase I Clinical Trial for Liver Cancer13 December 2013
Tekmira’s Anti-Ebola Program to Proceed in Clinical Study With More Potent Formulation10 December 2013
Adaptimmune Announces Interim Results from a Phase I/II Trial of Engineered T Cells Targeting Cancer Testis Antigens in Multiple Myeloma10 December 2013
ProNAi Therapeutics Reports Anti-Tumor Activity from Ongoing Phase II Clinical Study of PNT2258, a Novel BCL2-Inhibitor, at ASH Annual Meetin9 December 2013
Interim Phase IIa Results for Spiegelmer Olaptesed Pegol (NOX-A12) in CLL and MM Studies8 December 2013
Research Study of T Cell Immunotherapy Continues to Show Highly Promising Results in Children and Adults with Leukemia7 December 2013
ZIOPHARM Reports Positive Interim Results in Patients With Advanced Melanoma From Ongoing Phase 1/2 Study of Ad-RTS-IL-124 December 2013
Idera Pharmaceuticals Opens Enrollment for Phase 1/2 Clinical Trial of IMO-8400 in Waldenström’s Macroglobulinemia4 December 2013
Mesoblast Reports Positive Type 2 Diabetes Trial ResultsNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports